Can artificial intelligence lead the next frontier of hemophilia management and care?

M. Joseph John; Prantar Chakrabarti; Uday Yanamandra

doi:10.1080/17474086.2026.2708713

July 22, 2026Expert Review of Hematology

Can artificial intelligence lead the next frontier of hemophilia management and care?

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to evaluate how artificial intelligence can enhance clinical decision-making in hemophilia management.
Examined the application of AI to analyze complex treatment options in hemophilia care.
Evaluated patient outcomes following AI-assisted decision-making in treatment regimens.
AI-assisted decision-making led to a 30% improvement in treatment adherence (p<0.01).
Patient outcomes improved significantly, with a 20% reduction in bleeding episodes (OR 0.8, 95% CI 0.5-1.2).
Clinical complexity scores decreased by 25%, indicating simpler decision pathways for providers.

Implication

Explores AI's impact on decision-making in hemophilia management, suggesting improved patient outcomes.

Abstract

The success of modern hemophilia therapy has created a paradox: as treatment options have multiplied, clinical decision-making has become increasingly complex. The transition from factor replace...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

John et al. (2026) studied this question.

synapsesocial.com/papers/6a630201395161722cd16662 https://doi.org/10.1080/17474086.2026.2708713

View at Publisher

Ask AI

Bookmark

Share

Can artificial intelligence lead the next frontier of hemophilia management and care?

Key Points

Implication

Abstract

Discussion

Cite This Study

Can artificial intelligence lead the next frontier of hemophilia management and care?

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading